|

Oral Semaglutide Clinical Trials

3 actively recruiting trials across 1 location

No change since May 2026

Also known as: Rybelsus

Pipeline

Phase 4: 2

Top Sponsors

  • University Medical Centre Ljubljana1
  • Novo Nordisk A/S1
  • Massachusetts General Hospital1

Indications

  • Diabetes3
  • Type 2 Diabetes2
  • Metabolic Diseases1
  • Type 2 Diabetes Mellitus (T2DM)1
  • Genetic Predisposition1

Other2 trials

Effect of Early Combination Antihyperglycemic Treatment on Metabolic Control in Individuals With Type 2 Diabetes
Phase 4
SEMA-CardioDiab HUNGARY: A Research Study to Understand the Effects of Oral Semaglutide on Blood Sugar Levels, Weight, and Cardiovascular Risk in People With Type 2 Diabetes Patients in Hungary

Boston, Massachusetts1 trial

GLUCOSE-MGH: Genetic Links Understood Through Challenge With Oral Semaglutide Exposure at MGH

Massachusetts General Hospital

Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.